Cargando…
Prediction of Alzheimer's Pathological Changes in Subjective Cognitive Decline Using the Self-report Questionnaire and Neuroimaging Biomarkers
BACKGROUND AND PURPOSE: Subjective cognitive decline (SCD) may be the first symptomatic stage of Alzheimer's disease (AD). Hence, a screening tool to characterize the patients' complaints and assess the risk of AD is required. We investigated the SCD neuroimaging biomarker distributions an...
Autores principales: | Hong, Yun Jeong, Park, Kyung Won, Kang, Do-Young, Lee, Jae-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Dementia Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494779/ https://www.ncbi.nlm.nih.gov/pubmed/31097969 http://dx.doi.org/10.12779/dnd.2019.18.1.19 |
Ejemplares similares
-
Subjective Cognitive Decline and Alzheimer's Disease Spectrum Disorder
por: Hong, Yun Jeong, et al.
Publicado: (2017) -
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
por: Wang, Xiaoqi, et al.
Publicado: (2020) -
Electroencephalography for Early Detection of Alzheimer’s Disease in Subjective Cognitive Decline
por: Shim, YongSoo, et al.
Publicado: (2022) -
Development of a home-based cognitive test for cognitive monitoring in subjective cognitive decline with high risk of Alzheimer’s disease
por: Hong, Yun Jeong, et al.
Publicado: (2023) -
Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: the CoSCo prospective cohort study
por: Hong, Yun Jeong, et al.
Publicado: (2023)